Loading clinical trials...
Loading clinical trials...
A Phase II Multicenter Uncontrolled Trial of BAY43-9006 in Subjects With Metastatic Breast Cancer.
Conditions
Interventions
Sorafenib (Nexavar, BAY43-9006)
Locations
7
Germany
Stuttgart, Baden-Wurttemberg, Germany
München, Bavaria, Germany
Frankfurt am Main, Hesse, Germany
Bologna, Italy
Milan, Italy
Milan, Italy
Start Date
February 1, 2004
Primary Completion Date
January 1, 2006
Completion Date
January 1, 2008
Last Updated
December 13, 2013
NCT05245812
NCT04704661
NCT05673200
NCT04550494
NCT05372640
NCT07191730
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions